$24.44
-2.48-9.21%
Last update: Oct 26, 4:03 AM
Parabilis Medicines Inc (PBLS) Stock Price, Quote, News & History
PBLSNASDAQ
U.S. stocks mixed as Dow fell ~100 points; Silence Therapeutics surged 125.7% on Merck KGaA buyout, while biotech and tech shares gained.
You can purchase shares of Parabilis Medicines (NASDAQ:PBLS) through any online brokerage.
Other companies in Parabilis Medicines’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Parabilis Medicines has a consensus price target of $41.25.
The stock price for Parabilis Medicines (NASDAQ: PBLS) is $25 last updated October 26, 2026 at 4:03 AM EDT.
There are no upcoming dividends for Parabilis Medicines.
Parabilis Medicines does not have any upcoming earnings scheduled.
There is no upcoming split for Parabilis Medicines.
Parabilis Medicines is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide...
